General Information of Drug Off-Target (DOT) (ID: OTXGZ8FV)

DOT Name Securin-2 (PTTG2)
Synonyms Pituitary tumor-transforming gene 2 protein
Gene Name PTTG2
Related Disease
Esophageal squamous cell carcinoma ( )
Non-small-cell lung cancer ( )
Psoriasis ( )
UniProt ID
PTTG2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF04856
Sequence
MATLIYVDKEIGEPGTRVAAKDVLKLESRPSIKALDGISQVLTRRFGKTYDAPSALPKAT
RKALGTVNRATEKSVKTNGPRKQKQPSFSAKKMTEKTVKTKSSVPASDDAYPEIEKFFPF
NLLDFESFDLPEERQIAHLPLSGVPLMILDEEGELEKLFQLGPPSPVKMPSPPWECNLLQ
SPSSILSTLDVELPAVCYDIDI
Tissue Specificity Expressed at low levels in the pituitary, liver, spleen, prostate, testis, ovary, small intestine and colon. Also expressed in various pituitary, testicular, liver and ovarian tumors.
KEGG Pathway
Cell cycle (hsa04110 )
Oocyte meiosis (hsa04114 )
Human T-cell leukemia virus 1 infection (hsa05166 )

Molecular Interaction Atlas (MIA) of This DOT

3 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Esophageal squamous cell carcinoma DIS5N2GV Strong Altered Expression [1]
Non-small-cell lung cancer DIS5Y6R9 Strong Altered Expression [2]
Psoriasis DIS59VMN Strong Biomarker [3]
------------------------------------------------------------------------------------
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Securin-2 (PTTG2). [4]
Calcitriol DM8ZVJ7 Approved Calcitriol decreases the expression of Securin-2 (PTTG2). [6]
Testosterone DM7HUNW Approved Testosterone decreases the expression of Securin-2 (PTTG2). [6]
------------------------------------------------------------------------------------
3 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Arsenic DMTL2Y1 Approved Arsenic affects the methylation of Securin-2 (PTTG2). [5]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Securin-2 (PTTG2). [7]
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 decreases the phosphorylation of Securin-2 (PTTG2). [8]
------------------------------------------------------------------------------------

References

1 The Pseudogene PTTG3P Promotes Cell Migration and Invasion in Esophageal Squamous Cell Carcinoma.Open Med (Wars). 2019 Jun 30;14:516-522. doi: 10.1515/med-2019-0057. eCollection 2019.
2 Distinct expression pattern and prognostic values of pituitary tumor transforming gene family genes in non-small cell lung cancer.Oncol Lett. 2019 Nov;18(5):4481-4494. doi: 10.3892/ol.2019.10844. Epub 2019 Sep 10.
3 Pituitary tumor transforming gene PTTG2 induces psoriasis by regulating vimentin and E-cadherin expression.Int J Clin Exp Pathol. 2015 Sep 1;8(9):10887-93. eCollection 2015.
4 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
5 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
6 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
7 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
8 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.